PRESS RELEASE
Villers-lès-Nancy, 27 November 2013 - 6:30 p.m. (CET)
The PHARMAGEST Group rewarded at the 4th edition of Technology Fast 50 by Deloitte In Extenso
.
The PHARMAGEST Group, French leader in software for pharmacies, was awarded the "Bbifrance" award at the 4th edition of Technology Fast 50 East organised by Deloitte In Extenso in Metz on the 19th of November 2013.
Didier PICHOT, Regional Director of Bpifrance LORRAINE, presented Mr Thierry CHAPUSOT, Chairman of the Board of Directors and Mr Dominique PAUTRAT, CEO of the PHARMAGEST GROUP, with the Bpifrance award.
Technology Fast 50 awards and encourages the most successful technology companies, vanguards of the economy in their regions, who are capable of combining innovation and growth in high technology.
Each year, the Bpifrance award honours the company whose policy of innovation is considered the best from the list of contenders in France. The PHARMAGEST Group was awarded for its strong innovation policy. And, for the jury, the PHARMAGEST Group also distinguished itself by its strong development in recent years, and its success story, with 1 of every 2 pharmacies equipped in France.
On this occasion, Dominique PAUTRAT said, "When the PHARMAGEST Group talks about innovation, we mean first creating "innovative services" that anticipate the needs of our clients. That is something our Group has been committed to since its inception. This award by Bpifrance epitomises what we value when it comes to thinking about innovation, and otherwise developing service. At PHARMAGEST, innovative services involve experience and client relationships and, of course, technology and R&D. On behalf of all of our teams, we are very proud to have received this distinction."
Currently, more than 1,500 companies participate in this list. They demonstrate that it is possible to innovate and create value, even in a fragile economic environment. This success also reflects the liveliness of innovation and the dynamism of accompanying structures.
About the PHARMAGEST Group:
The PHARMAGEST Group is the French leader in computer systems for pharmacies, with a 43.5 % share of the market, 9,800 clients and more than 700 employees. Since September 2007, the PHARMAGEST Group has also been present in Northern Europe with a 12 % market share in Belgium and Luxembourg through its subsidiary SABCO.
As a privileged partner to pharmacists for almost 30 years now, the PHARMAGEST Group designs innovative computer solutions for pharmacies and is developing a high potential E-Business E-Media activity intended for laboratories.
The PHARMAGEST Group is also developing previously unpublished software solutions for Retirement Homes, (Care Homes and day centres for the elderly), through its subsidiary MALTA INFORMATIQUE.
The first Logiciel de Gestion à Portail Intégré (Integrated Portal Management Software - LGPI Global Services®), creator of value for the patient, pharmacist and laboratory, dynamises sales, optimises purchases and enriches advice to the patient. It is also the first permanent impact medium for pharmacies, supplying laboratories with direct communication towards the pharmacist and his patients.
At the heart of the digital revolution that is gradually establishing itself in the daily life of health professionals and patients alike, at the beginning of 2012, the PHARMAGEST Group created an e-Health business, bringing together the subsidiaries DIATELIC (telemedicine and e-health solutions) and DOMEDIC EUROPE (intelligent pill dispenser DO-Pill SecuRTM).
Listed on the NYSE Euronext Paris(TM) - Compartment B
Eligible for the Long-Only Deferred Settlement Service (SRD)
Indices CAC ® SMALL90 and CAC ® All-Tradable by inclusion
ISIN: FR 0000077687 - Reuters: PHA.PA - Bloomberg: - PMGI FP
Find out the latest news from the group at www.pharmagest.com
CONTACTS
Chairman of the Board:
Thierry CHAPUSOT
Chief Executive Officer:
Dominique PAUTRAT
Tel. 03 83 15 90 67 - dominique.pautrat@pharmagest.com
Analyst and Investor Relations:
Administrative and Financial Director: Jean-Yves SAMSON
Tel. 03 83 15 90 67 - jean-yves.samson@pharmagest.com
Press relations:
FIN'EXTENSO - Isabelle APRILE
Tel.01 39 97 61 22 - i.aprile@finextenso.fr
